The Current Ratio as of October 2024 (TTM) for Acorda Therapeutics, Inc. (ACOR) is 0.22

According to Acorda Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.22. This represents a change of -79.75% compared to the average of 1.07 of the last 4 quarters.

Acorda Therapeutics, Inc. (ACOR) Historical Current Ratio (quarterly & annually)

How has ACOR Current Ratio performed in the past?

The mean historical Current Ratio of Acorda Therapeutics, Inc. over the last ten years is 2.56. The current 0.22 Current Ratio has changed 744.77% with respect to the historical average. Over the past ten years (40 quarters), ACOR's Current Ratio was at its highest in in the June 2014 quarter at 8.50. The Current Ratio was at its lowest in in the March 2024 quarter at 0.22.

Acorda Therapeutics, Inc. (ACOR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Acorda Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acorda Therapeutics, Inc. (ACOR) Average Current Ratio

How has ACOR Current Ratio performed in the past?

The current Current Ratio of Acorda Therapeutics, Inc. (ACOR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Acorda Therapeutics, Inc. (ACOR) Current Ratio vs. Peers

How is ACOR’s Current Ratio compared to its peers?

Acorda Therapeutics, Inc.’s Current Ratio is less than Taisho Pharmaceutical Holdings Co., Ltd. (5.16), less than Shionogi & Co., Ltd. (6.22), less than Vivesto AB (3.17), less than Pacira BioSciences, Inc. (6.82), less than Sunshine Biopharma, Inc. (4.86), less than Lucy Scientific Discovery Inc. (0.38), less than Biofrontera Inc. (1.89), less than Jupiter Wellness, Inc. (1.92), less than Shuttle Pharmaceuticals Holdings, Inc. (1.79), less than Lifecore Biomedical, Inc. (1.83), less than Journey Medical Corporation (1.36), less than Akanda Corp. (1.41), less than China Pharma Holdings, Inc. (0.84), less than Universe Pharmaceuticals INC (1.63), less than Sonoma Pharmaceuticals, Inc. (3.12), less than Petros Pharmaceuticals, Inc. (1.40), less than Evoke Pharma, Inc. (1.28), less than Cumberland Pharmaceuticals Inc. (1.44), less than Agile Therapeutics, Inc. (0.55), less than PainReform Ltd. (0.61),

Build a custom stock screener for Acorda Therapeutics, Inc. (ACOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acorda Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acorda Therapeutics, Inc. (ACOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acorda Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.